In public relations, “embargoed information” refers to sensitive data, figures and any other sort of information that can only be made public at a later time, usually because said information is expected to affect the organization’s share prices.
“In an unusual arrangement, the American Diabetes Association let hundreds, if not thousands, of in-person attendees see new data on Novo Nordisk’s blockbuster diabetes treatment Victoza more than an hour before its official release to the public and the markets.
…After warning attendees not to share the information they were about to post, presenters put up slides showing that Bagsvaerd, Denmark-based Novo’s drug cut heart attacks and strokes by 13 percent and improved survival, while also lowering blood sugar rates and a host of other complications. While good news for diabetics, it was less than investors had hoped.
Within minutes, some Twitter account were posting pictures of the charts, including key slides that showed the drug’s success in reducing deaths. And as fast as the posts went up, the medical society’s communications team issued online pleas for them to stop.”
Read the full article at the Denver Post here.